AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rabitra D 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Astrica Biomedics Pvt Ltd

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Rabitra D 30mg/20mg Capsule SR

Gastroesophageal reflux disease (GERD, or acid reflux) is effectively managed with Rabitra D 30mg/20mg SR Capsules, a dual-action formulation. This medication alleviates common GERD symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Rabitra D should be taken on an empty stomach, following your physician's prescribed dosage and duration. Treatment length depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence or condition worsening. Complete disclosure of all other medications to your healthcare provider is crucial, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal discomfort, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring alertness until the drug's impact is known. Alcohol consumption should be avoided due to potential increased sleepiness. Lifestyle adjustments, such as consuming cool milk and avoiding stimulants like coffee, tea, spicy food, and chocolate, may enhance treatment effectiveness. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, as well as pregnancy, pregnancy planning, or breastfeeding.

Uses of Rabitra D 30mg/20mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Rabitra D 30mg/20mg Capsule SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rabitra D 30mg/20mg SR capsule whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Rabitra D 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Rabitra D 30mg/20mg Capsule SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the entire capsule without chewing, crushing, or breaking it. Rabitra D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.

How Rabitra D 30mg/20mg Capsule SR works:

Rabitra D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract movement, facilitating efficient food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from acid indigestion and heartburn symptoms.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Rabitra D 30mg/20mg SR capsules with alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Rabitra D 30mg/20mg SR capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Rabitra D 30mg/20mg capsules are likely not safe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Rabitra D 30mg/20mg sustained-release capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Rabitra D 30mg/20mg sustained-release capsules. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Rabitra D 30mg/20mg SR capsules; dosage modification may be necessary. Consult a physician before use. Rabitra D 30mg/20mg SR capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.

What if you forget to take Rabitra D 30mg/20mg Capsule SR :

Should you forget a Rabitra D 30mg/20mg SR Capsule dose, take it immediately if you remember. However, near the time for your next dose, omit the missed one and resume your usual schedule. Never take a double dose.

Facts to Know About Rabitra D 30mg/20mg Capsule SR

LabelValue
Potential for Dependence None.
Type of Medication Stomach and intestinal

FAQs on Rabitra D 30mg/20mg Capsule SR

Rabitra D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This formulation addresses heartburn, acid reflux (GERD – gastroesophageal reflux disease), where stomach acid rises into the esophagus, and also treats gastric and duodenal ulcers. The domperidone component facilitates improved gut motility, thus reducing vomiting by expediting food passage through the stomach.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any inactive components within Rabitra D 30mg/20mg SR Capsules should avoid its use. Individuals with pre-existing liver or kidney conditions require careful monitoring when considering this medication.
Indeed, Rabitra D 30mg/20mg SR capsules may induce xerostomia. This side effect is attributed to the domperidone component. To alleviate dryness, increase your water consumption. Keep a water source readily available overnight. Reduce alcohol consumption and abstain from smoking. If experiencing dry mouth, utilize an alcohol-free mouthwash to minimize potential dental caries.
Diarrhea is a possible side effect of Rabitra D 30mg/20mg SR Capsules. If diarrhea occurs, increase fluid intake. Restrict consumption of greasy or deep-fried foods while taking this medication. Consult your physician if diarrhea continues or you observe dehydration symptoms such as reduced urination and dark, concentrated urine.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Rabitra D 30mg/20mg SR capsules are generally well-tolerated. Nevertheless, some individuals may experience typical side effects such as diarrhea, abdominal pain, gas, dry mouth, vertigo, or headache. Less frequent or infrequent adverse reactions are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Rabitra D 30mg/20mg sustained-release capsules is before breakfast or on an empty stomach.
Taking Rabitra D 30mg/20mg sustained-release capsules may elevate the likelihood of experiencing an abnormal heart rhythm (severe arrhythmias). While this is a significant potential adverse effect, the probability of occurrence remains quite small. However, individuals over 60 might face a marginally increased risk.
Rabitra D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This formulation addresses symptoms of heartburn, acidity, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It's also indicated for treating gastric and duodenal ulcers. The domperidone component facilitates improved gut motility, thus managing nausea and vomiting by expediting food passage through the stomach.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any excipient within Rabitra D 30mg/20mg SR Capsules should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Indeed, Rabitra D 30mg/20mg SR capsules may induce xerostomia (dry mouth), a side effect attributed to the Domperidone component. To alleviate this, increase your water consumption. Keep a water source readily available overnight. Reduce alcohol consumption and refrain from smoking. For dry mouth, utilize alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a possible side effect of Rabitra D 30mg/20mg SR Capsules. If diarrhea occurs, increase your fluid intake. Refrain from consuming greasy or fried foods while taking this medication. Consult your physician if diarrhea continues or you observe dehydration symptoms such as reduced urination and dark, concentrated urine.
Rabitra D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience side effects including, but not limited to, diarrhea, abdominal pain, flatulence, dry mouth, vertigo, and cephalalgia. Less frequent or infrequent adverse reactions are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Rabitra D 30mg/20mg sustained-release capsules is before breakfast or on an empty stomach.
Taking Rabitra D 30mg/20mg SR capsules may raise the likelihood of an irregular heartbeat, a severe but uncommon adverse event. This risk might be marginally greater for individuals over 60.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Rabitra D 30mg/20mg Capsu...
81
MRP 99
18% off